The Global Autoimmune Disease Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies
Posted on 05 March 2015
The Global Autoimmune Disease Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies
Posted on 23 September 2014
Recent market research analysis by Current Agreements shows that partnering in the last decade has seen an increase in cardiovascular deals with an increase in modern diagnostic technology development.
Posted on 02 September 2014
By Shamini Thiagarajan Increased collaborations, big pharma involvements, venture capital investments, and medical/technological breakthroughs are together changing the landscape of research and development in orphan diseases.
Posted on 07 August 2014
Current Partnering releases its first update of the article previously published last year on the most partnered therapeutic trends in pharma. The article analyses the most partnered therapeutic targets of 2009-2014 and identifies the areas that have gained in popularity since last year and the new areas that have entered the list
Posted on 23 July 2014
Partnering in the last decade has seen an increase in dermatology with an rise specifically in modern diagnostic technologies.
Posted on 14 July 2014
Partnering in the last decade has seen an increase in oncology partnering with an increase in modern diagnostic technologies, according to recent partnering deals analysis
Posted on 17 June 2014
Recent trends analysis suggests that research in personalized medicine and vaccine development for disease treatment has increased partnering and collaboration in this arena.
Posted on 09 June 2014
Deal analysis by Current Agreements shows that ophthalmics dealmaking activity has been steady with an average of 68 deals signed since 2009.
Posted on 18 February 2014
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
Posted on 08 January 2014
Scientists predict that the cure to cancer in the future lies in exploiting personalized medicine technology.